VIMTA LABS
Back to Cashflow Statement
|
VIMTA LABS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹61 Cr | ₹88 Cr | ₹59 Cr | ₹37 Cr | ₹24 Cr |
What is the latest Cash Flow from Operating Activities ratio of VIMTA LABS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2024 | ₹61 Cr |
| Mar2023 | ₹88 Cr |
| Mar2022 | ₹59 Cr |
| Mar2021 | ₹37 Cr |
| Mar2020 | ₹24 Cr |
How is Cash Flow from Operating Activities of VIMTA LABS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2024 | ₹61 Cr | -30.75 | |
| Mar2023 | ₹88 Cr | 48.87 | |
| Mar2022 | ₹59 Cr | 58.86 | |
| Mar2021 | ₹37 Cr | 52.71 | |
| Mar2020 | ₹24 Cr | - | |
Compare Cash Flow from Operating Activities of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹2,717.5 Cr | 1.2% | -9.5% | 37.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹439,378.0 Cr | 2.8% | 6.7% | 2.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,996.0 Cr | 1.9% | -0.5% | 6.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,959.0 Cr | 0.1% | 3.4% | 15.8% | Stock Analytics | |
| CIPLA | ₹123,666.0 Cr | 1.8% | -3.2% | 2.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,008.0 Cr | 2.7% | 0.4% | 3.4% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | 1.2% |
-9.5% |
37.8% |
| SENSEX | 0.6% |
1.3% |
7% |
You may also like the below Video Courses